COMMENTARY

• The First Round Results of GE Amlodipine (2)- Making No Surprise Moves Leads to Success -
  April 6, 2009

• COMMENTARY／Worst Scenario Coming True due to Heated Competition among Wholesalers
  March 23, 2009

• Unexpected Demand for ActHIB Causes Shortage of Supply
  March 16, 2009

• COMMENTARY／Aggressive Overseas Investments Affect Business of Top-4 Pharmas
  February 23, 2009

• COMMENTARY／National Consensus Needed to Balance Soaring Costs of New Drugs against Their Benefits
  February 16, 2009

• Majority of People Have Misconceptions about Antibacterials: Pfizer Survey
  February 9, 2009

• Patent Expiration of Blockbusters and New Breakthrough Candidates from Japanese Pharmaceutical Companies
  February 9, 2009

• Paltac/Alfresa Merger Plan Canceled, but Distribution Reform Remains to Be Done
  February 2, 2009

• COMMENTARY／Industry Should Guarantee Development of Innovative Drugs and Use of More Generics
  January 19, 2009

• COMMENTARY／Aiming at Further Growth beyond Global Recession
  January 12, 2009

• COMMENTARY／Rule to Restrict Participation in CDFS Committee Deliberations Needs Continued Validation
  January 5, 2009

• COMMENTARY／Will Economic Incentives for Med. Institutions Be Effective to Promote Use of Generics?
  December 22, 2008

• Commentary／Issue of Online Sales of OTC Drugs at Standstill
  December 15, 2008

• COMMENTARY／Toyota, NEC Start Direct Inspection, Payment of Medical Bills
  December 8, 2008

• COMMENTARY／Will VITAL KSK Become Core of Alliance of Regional Wholesalers?
  December 8, 2008

• SURVEY／DPP-4 Inhibitors May Decrease Consumption of SUs
  December 1, 2008

• COMMENTARY／Thinking about Why Megapharmas Are Closing Research Labs in Japan
  November 24, 2008

• COMMENTARY／Marriage of Nos. 1 and 2 Wholesalers Creates Sensation in Market
  November 3, 2008

• COMMENTARY／Competition Intensifies for Development of DPP-4 Inhibitors
  September 22, 2008

• COMMENTARY／Yamato Searches for a Way to Start Generics Distribution Business
  September 22, 2008

ページ